JG
VNDA icon

Jefferies Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Jefferies Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,914
Closed -$61.4K – 1964
2021
Q4 		$61.4K Buy
+3,914
New +$68.2K ﹤0.01% 1511
2020
Q1 		– Sell
-14,763
Closed -$242K – 2710
2019
Q4 		$242K Sell
14,763
-30,093
-67% -$455K ﹤0.01% 2165
2019
Q3 		$596K Buy
+44,856
New +$625K ﹤0.01% 1788
2018
Q2 		– Sell
-11,120
Closed -$187K – 2706
2018
Q1 		$187K Buy
+11,120
New +$186K ﹤0.01% 1987
2017
Q2 		– Sell
-21,021
Closed -$294K – 2593
2017
Q1 		$294K Buy
+21,021
New +$300K ﹤0.01% 1840
2016
Q4 		– Sell
-101,771
Closed -$1.69M – 2511
2016
Q3 		$1.69M Buy
101,771
+33,907
+50% +$456K 0.01% 1010
2016
Q2 		$759K Buy
+67,864
New +$657K ﹤0.01% 1247
2015
Q4 		– Sell
-27,533
Closed -$275K – 2594
2015
Q3 		$311K Sell
27,533
-57,115
-67% -$699K ﹤0.01% 1744
2015
Q2 		$1.07M Sell
84,648
-745,754
-90% -$8.04M 0.01% 1210
2015
Q1 		$7.72M Buy
+830,402
New +$9.38M 0.04% 296
2014
Q4 		– Sell
-225,634
Closed -$2.67M – 2362
2014
Q3 		$2.34M Buy
225,634
+170,791
+311% +$2.24M 0.02% 664
2014
Q2 		$887K Buy
+54,843
New +$730K 0.01% 958
2013
Q4 		– Sell
-18,100
Closed -$182K – 2248
2013
Q3 		$198K Buy
+18,100
New +$193K ﹤0.01% 1617

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Jefferies Group's VNDA Position: Q1 2022 in Review

Jefferies Group sold out of Vanda Pharmaceuticals (VNDA) in Q1 2022, closing a stake of 3,914 shares — an estimated $61.4K sold.

Jefferies Group first reported a position in VNDA in Q3 2013 and held it in 13 quarters. The position peaked at $7.72M in Q1 2015. 188 funds tracked by Wall St. Rank hold VNDA as of Q1 2022.

  • Jefferies Group reported no remaining Vanda Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Jefferies Group sold 3,914 Vanda Pharmaceuticals shares in Q1 2022, an estimated $61.4K.
  • Jefferies Group first reported a position in Vanda Pharmaceuticals in Q3 2013 and held it in 13 quarters.
  • Jefferies Group's Vanda Pharmaceuticals position peaked at $7.72M in Q1 2015.
  • 188 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2022.

Based on Jefferies Group's 13F filing for Q1 2022, filed 16 May 2022.